Vitamin D Alleviates Cadmium-Induced Inhibition of Chicken Bone Marrow Stromal Cells’ Osteogenic Differentiation In Vitro
Open Access
Abstract
Vitamin D is a lipid soluble vitamin that is mostly used to treat bone metabolism-related diseases. In this study, the effect of Cd toxicity in vitro on osteogenic differentiation derived from BMSCs and the alleviating effect of lα, 25-(OH)2D3 were investigated. Cell index in real time was monitored using a Real-time cell analyzer (RTCA) system. The activity of alkaline phosphatase (ALP), and the calcified nodules and the distribution of Runx2 protein were detected using ALP staining, alizarin red staining, and immunofluorescence, respectively. Furthermore, the mitochondrial membrane potential and the apoptotic rate of BMSCs, the mRNA levels of RUNX2 and type Ⅰ collagen alpha2 (COL1A2) genes, and the protein expression of Col1 and Runx2 were detected using flow cytometry, qRT-PCR and western blot, respectively. The proliferation of BMSCs and osteogenic differentiation were enhanced after treatment with different concentrations of lα, 25-(OH)2D3 compared with the control group. However, 5 μmol/L Cd inhibited the proliferation of BMSCs. In addition, 10 nmol/L lα,25-(OH)2D3 attenuated the toxicity and the apoptosis of BMSCs treated by Cd, and also promoted the osteogenic differentiation including the activity of ALP, and the protein expression of Col1 and Runx2. lα, 25-(OH)2D3 can alleviate cadmium-induced osteogenic toxicity in White Leghorn chickens in vitro.Keywords
Funding Information
- The National Natural Science Foundation of China (32102732, 31872534, 31872533, BK20210806)
- the Jiangsu Provincial Natural Science Foundation of China (32102732, 31872534, 31872533, BK20210806)
- the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (32102732, 31872534, 31872533, BK20210806)
This publication has 59 references indexed in Scilit:
- High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitroInternational Journal of Molecular Medicine, 2012
- Genetic and Transcriptional Control of Bone FormationOral and Maxillofacial Surgery Clinics of North America, 2010
- The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful agingThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Immature Osteoblast Lineage Cells Increase Osteoclastogenesis in Osteogenesis Imperfecta MurineThe American Journal of Pathology, 2010
- Osteo-transcriptomics of human mesenchymal stem cells: Accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesisBone, 2010
- Perspectives onRUNXgenes: An updateAmerican Journal of Medical Genetics Part A, 2009
- Evidence for auto/paracrine actions of vitamin D in bone: 1a‐hydroxylase expression and activity in human bone cellsThe FASEB Journal, 2006
- High vitamin D 3 requirements in broilers for bone quality and prevention of tibial dyschondroplasia and interactions with dietary calcium, available phosphorus and vitamin ABritish Poultry Science, 2004
- Effects of Cadmium Intake on Bone Metabolism of Mothers during Pregnancy and Lactation.The Tohoku Journal of Experimental Medicine, 2002
- DIFFERENTIAL EFFECTS OF TRANSFORMING GROWTH FACTOR β2, DEXAMETHASONE AND 1,25-DIHYDROXYVITAMIN D ON HUMAN BONE MARROW STROMAL CELLSCytokine, 1997